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Cassava brown streak disease (CBSD) presents a serious threat to cassava production
in East and Central Africa. Currently, no cultivars with high levels of resistance to CBSD
are available to farmers. Transgenic RNAi technology was employed to combat CBSD by
fusing coat protein (CP) sequences from Ugandan cassava brown streak virus (UCBSV)
and Cassava brown streak virus (CBSV) to create an inverted repeat construct (p5001)
driven by the constitutive Cassava vein mosaic virus promoter. Twenty-five plant lines
of cultivar TME 204 expressing varying levels of small interfering RNAs (siRNAs) were
established in confined field trials (CFTs) in Uganda and Kenya. Within an initial CFT at
Namulonge, Uganda, non-transgenic TME 204 plants developed foliar and storage root
CBSD incidences at 96–100% by 12 months after planting. In contrast, 16 of the 25
p5001 transgenic lines showed no foliar symptoms and had less than 8% of their storage
roots symptomatic for CBSD. A direct positive correlation was seen between levels of
resistance to CBSD and expression of transgenic CP-derived siRNAs. A subsequent CFT
was established at Namulonge using stem cuttings from the initial trial. All transgenic
lines established remained asymptomatic for CBSD, while 98% of the non-transgenic
TME 204 stake-derived plants developed storage roots symptomatic for CBSD. Similarly,
very high levels of resistance to CBSD were demonstrated by TME 204 p5001 RNAi
lines grown within a CFT over a full cropping cycle at Mtwapa, coastal Kenya. Sequence
analysis of CBSD causal viruses present at the trial sites showed that the transgenic lines
were exposed to both CBSV and UCBSV, and that the sequenced isolates shared >90%
CP identity with transgenic CP sequences expressed by the p5001 inverted repeat
expression cassette. These results demonstrate very high levels of field resistance to
CBSD conferred by the p5001 RNAi construct at diverse agro-ecological locations, and
across the vegetative cropping cycle.
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INTRODUCTION
Cassava brown streak disease (CBSD) is a major constraint to
cassava (Manihot esculenta) production in sub-Saharan Africa.
The World Health Organization (WHO) has identified CBSD as
one of the world’s most serious threats to food security (WHO,
2011). A recent survey conducted in villages of Kenya, Tanzania,
Uganda, and Malawi estimated losses due to CBSD at about
US$750 million annually (Hillocks and Maruthi, 2015). CBSD
is caused by two positive-sense single strand RNA (+ssRNA)
viruses:Cassava brown streak virus (CBSV) andUgandan Cassava
brown streak virus (UCBSV), belonging to the genus Ipomovirus,
family Potyviridae (Mbanzibwa et al., 2009; Winter et al., 2010;
Ndunguru et al., 2015). Viruses that cause CBSD are transmitted
semi-persistently by the whitefly vector Bemisia tabaci (Maruthi
et al., 2005; Mware et al., 2009) and can occur as single or dual
infections (Mbanzibwa et al., 2011).
For many years, CBSD was geographically restricted to the
lower coastal regions of East Africa (Hillocks et al., 2001) before
being confirmed as present in Uganda in the mid-2000s (Alicai
et al., 2007). Since that time, it has spread to the higher altitude
areas of East andCentral Africa (Legg et al., 2011, 2015; Patil et al.,
2015) and now threatens the large cassava-producing countries
of West Africa. The rapid spread of CBSD to reach epidemic
proportions in East and Central Africa has been linked to a
“super-abundance” of whitefly vectors and associated with the
evolving environmental and climatic conditions occurring within
the region (Jeremiah et al., 2015).
CBSD symptoms vary depending on the cassava variety, the
environmental conditions under which the crop is grown and
the CBSD-causing species involved, with CBSV themore virulent
of the two species (Winter et al., 2010; Mohammed et al., 2012;
Alicai et al., 2016; Ogwok et al., 2016). CBSD leaf symptoms
are characterized by feathery chlorosis along veins and chlorotic
mottling in older leaves. Stem symptoms appear as brown
necrotic lesions with die-back from the shoot tip occurring
in severe cases. The most economically important impact of
CBSD occurs within the storage roots, where symptoms appear
as brown, corky, necrotic lesions. This renders affected roots
unusable as a source of food and valueless in the marketplace.
With cassava central to food and economic security throughout
much of East and Central Africa (Fermont et al., 2010) the impact
of CBSD has important implications for smallholder cassava
farmers, rural communities and growing industries dependent on
cassava as raw material. Development and deployment of CBSD-
tolerant/resistant germplasm suited to farmers’ needs is therefore
essential if the impact of CBSD is to be mitigated (Legg et al.,
2011).
The efficacy of RNA interference (RNAi) technology to
generate resistance against CBSD was first demonstrated
in tobacco by transgenic expression of an inverted repeat
construct derived from the UCBSV coat protein (CP) sequence
(Patil et al., 2011). Experiments in cassava cultivar 60444
showed that transgenic lines harboring the UCBSV-CP RNAi
construct were 100% resistant to the homologous UCBSV after
grafting inoculation under greenhouse conditions, with no virus
detectable by RT-PCR in leaf and storage root tissues (Yadav
et al., 2011). Under confined field conditions at Namulonge,
Uganda, the same transgenic lines were found to be 100%
resistant to UCBSV (Ogwok et al., 2012), but susceptible to
infection by the non-homologous CBSV. The exception was
transgenic line 718-01 that expressed the highest level of siRNAs
derived from the UCBSV-CP sequence (Ogwok et al., 2012).
At harvest, 90% of storage roots from plants of the non-
transgenic controls were found to have severe root necrosis
as a result of CBSD infection. In contrast, 95% of roots
from transgenic line 718-01 were free of necrotic symptoms
and neither UCBSV or CBSV was detectable in 95% of the
storage roots (Ogwok et al., 2012). In a similar approach,
Vanderschuren et al. (2012) reported high levels of resistance
to CBSD under controlled growth conditions by expressing a
CBSV-CP inverted repeat construct in cassava cultivars 60444
and TME 7.
The Virus Resistant Cassava for Africa (VIRCA) project aims
to utilize RNAi to generate and deliver cassava with enhanced
resistance to CBSD to farmers in East Africa (Taylor et al., 2012).
Proof of concept in cassava cv. 60444 utilized the CP of UCBSV,
as this was the only sequence information available for a CBSD
causal pathogen in 2008. Access to additional genomic sequence
data for CBSV and UCBSV enabled development of an improved
RNAi construct in which near full-length CP sequences from
both CBSV and UCBSV were fused in tandem and expressed
as an inverted repeat driven by the Cassava vein mosaic virus
(CsVMV) promoter (p5001). Construct p5001 was transformed
into the Ugandan, farmer-preferred cv. TME 204 (Chauhan
et al., 2015), and high levels of resistance to both CBSV and
UCBSV were demonstrated by graft-inoculation experiments
in the greenhouse. Data indicated that levels of resistance
were positively correlated with levels of transgenically expressed
CP-derived siRNAs (Beyene et al., 2016a). Here we report
performance of p5001 TME 204 transgenic lines established in
confined field trials (CFT) at Namulonge, Uganda and Mtwapa,
coastal Kenya under conditions of naturally vector-transmitted
CBSD, and durability of resistance to CBSD across the vegetative
cropping cycle.
MATERIALS AND METHODS
Plant Preparation, Shipment, and
Hardening
Production of transgenic plants of cassava cv. TME 204 with
the inverted repeat construct p5001 was described previously by
Chauhan et al. (2015). Twenty-five p5001 transgenic plant lines
carrying 1–2 copies of the T-DNA were prepared and confirmed
for accumulating CP-derived siRNAs by Northern blot (Beyene
et al., 2016a). The 25 transgenic plants were micropropagated
along with non-transgenic wild-type TME 204 plantlets. A
total of 100 plantlets per line (event) were established in 50
mL Falcon tubes in a manner reported previously (Ogwok
et al., 2012). Plantlets were dispatched from the Donald
Danforth Plant Science Center (DDPSC), St. Louis, MO, USA
with the appropriate import and phytosanitary documents to
the National Crops Resources Research Institute (NaCRRI),
Namulonge, Uganda.
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Upon receipt at NaCRRI, plantlets were hardened in a
biosafety level II screenhouse in 100% humidity at 24–28◦C
under transparent polythene bags (Ogwok et al., 2012). After
4 weeks of growth in vermiculite, plants were transferred to
a mixture of vermiculite and sterilized soil at a 1:2 ratio and
maintained for an additional 4 weeks before transfer to the field.
Establishment of Confined Field Trial at
Namulonge, Uganda
A confined field trial (CFT) was established with 30 entries
at NaCRRI, Namulonge. The trial consisted of 25 independent
transgenic p5001 lines of cv. TME 204, two tissue culture-derived
non-transgenic TME 204 entries (WT1 and WT2) produced at
DDPSC, one stake cutting-derived entry of TME 204 (WT3), plus
two farmer-preferred cultivars NASE 3 (TMS 30572) and NASE
14 entries obtained locally from farmers’ fields. To ensure that
the materials collected from farmers’ fields were free of CMD and
CBSD, PCR and RT-PCR were performed prior to planting on
leaf samples as described previously (Ogwok et al., 2012).
After 8 weeks of growth in the screenhouse, hardened plants
were transferred to the CFT enclosure with an area of 67 ×
74m. Preparation of the field, transfer of plants and planting
was performed as described previously by Ogwok et al. (2012).
Plants were established in a randomized complete block design
(RCBD), consisting of eight replications and a plot configuration
of 10 plants per entry (paired parallel rows of five plants each)
at a spacing of 1 × 1 m. A single row of cassava stakes of cv.
TME 14 infected with CBSD was planted around each plot to
ensure maximum disease transmission to the test materials. Prior
to planting, the “spreader” TME 14 plants were tested by RT-PCR
(Ogwok et al., 2015) to ensure that they harbored both CBSV and
UCBSV. After planting in the field, plants were watered daily for
1 week and then three times per week thereafter. No fertilizers
or agrochemicals were applied to the plants. Hand weeding was
performed as and when required.
Establishment of Confined Field Trial at
Mtwapa, Kenya
A CFT was established at Mtwapa, coastal Kenya consisting of
a total of 21 entries. This included 19 transgenic p5001 TME
204 lines and two micropropagated wild-type TME 204 controls.
The 19 transgenic p5001 lines were a sub-set chosen from the
25 p5001 lines established in the CFT at Namulonge, Uganda
and included both high and low expressers of transgenic CP-
derived siRNAs. Establishment of plantlets in 50 mL Falcon
tubes at DDPSC, transport, transplanting and hardening of the
plants in a biosafety level II screenhouse at Kenya Agricultural
and Livestock Research Organization (KALRO) Biotech, Nairobi,
Kenya followed procedures as described above (Ogwok et al.,
2012). The Mtwapa CFT was established as a RCBD with four
replicates of 10 plants each and with a single row of the local
cassava cultivar Ex-mariakani showing CBSD symptoms used as
spreader row plants.
Establishment of Stake-Derived Field Trial
at Namulonge
Plants within the CFT at Namulonge were tested for presence
of CBSV and UCBSV at 6.5 months after planting as described
by Ogwok et al. (2012). Woody stem cuttings (length ∼15 cm)
were obtained from CBSD-free plants from three of the eight
replicates and used to establish a second trial. This trial consisted
of 15 entries, of which 11 were transgenic p5001 TME 204 lines,
two non-transgenic local varieties NASE 3 and NASE 14 and two
non-transgenic TME 204 (one obtained from wild-type plants of
the previous trial and the second from UCBSV/CBSV-free plants
collected from a farmer’s field). The trial was established in RCBD
with four replications, each plot having 25 plants per entry (5 ×
5 rows) at a spacing of 1 × 1m. A single row of cassava stakes
of cv. TME 14 infected with CBSD was planted around each plot
to ensure maximum disease pressure on the test materials. The
same agronomic practices were performed as described above.
Visual Assessment of CBSD Symptoms
Plants were visually assessed for CBSD and CMD symptoms
beginning 1 month after planting (MAP) and every month
thereafter. Severity of CBSD symptoms on shoots and stems of
plants within each plot were assessed and scored on a 1–5 scale
(Ogwok et al., 2012). Incidence was calculated as the percentage
of plants showing CBSD symptoms on leaves and stems per line.
Adult whiteflies (B. tabaci) present on the underside of the five
uppermost, fully expanded leaves of all experimental plants were
counted and recorded at Namulonge, Uganda.
In order to assess storage root damage due to CBSD, storage
roots were dug up using a hoe and assessed for CBSD necrosis.
Plants from three of the eight replicates (30 plants per line)
were harvested and evaluated at Namulonge at 6.5 MAP and the
remaining five replicates (50 plants per line) were harvested 12
MAP. Plants from the stake-derived CFT at Namulonge were
harvested for assessment of CBSD in the root at 8 MAP. At
Mtwapa, all plants were harvested and evaluated at 12 MAP.
Storage roots were weighed on a digital scale and each root was
sliced transversely along their length into five pieces. Each slice
was visually assessed for presence and severity of CBSD necrosis
on a 1–5 scale (Ogwok et al., 2012; Odipio et al., 2014), adapted
from that reported by Hillocks et al. (1996). Storage root CBSD
incidence was expressed as (a) percentage of plants per line that
showed CBSD symptoms in their storage roots and (b) number of
roots per line showing CBSD symptoms expressed as a percentage
of total number of roots harvested. Mean severity of CBSD was
calculated from the averages of individual root severity scores of
the symptomatic roots (scores of 2–5) per plot. The percentage of
marketable/usable roots was calculated as the number of roots
that showed severity of 1–2 (scale of 1–5) adopting breeders’
practices for line selection (Kawuki et al., 2016).
Sampling of Leaf and Storage Root Tissues
Leaf samples were picked randomly from five out of 10 plants
in each plot. The central leaf lobe was removed and placed
into a paper envelope and stored in a cool box containing ice.
Samples were taken to shaded area, removed from the envelope
and fastened onto newsprint using masking tape. Sheets of the
labeled samples were pressed in a plant press, transported to the
laboratory and stored at room temperature until required. For
storage root samples, three asymptomatic and three symptomatic
roots were picked at random from each plot. A transverse slice
was cut from storage roots using a kitchen knife. Samples were
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wrapped in aluminum foil, labeled and placed in a cool box with
ice, transported and stored at−80◦C.
Total RNA Extraction from Leaf and
Storage Root Samples
Five dried leaf samples collected from each plot were pooled
to generate one sample of approximately 0.20 g and used
for RNA extraction by the CTAB method (Lodhi et al.,
1994). For the root samples, ∼0.2 g of each was weighed and
RNA extracted using the CTAB method. All RNA extracts
were treated with DNase I and subjected to cDNA synthesis
using the Invitrogen Super-Script R© III First-Strand synthesis
kit. RT-PCR was performed on the synthesized cDNAs for
simultaneous detection of UCBSV and CBSV. Primers CBSVDF2
(5′-GCTMGAAATGCYGGRTAYACAA-3′) and CBSVDR (5′-
GGATATGGAGAAAGRKCTCC-3′) (Mbanzibwa et al., 2011)
were used to amplify about 437 and 343 bp of UCBSV and CBSV,
respectively. PCR products were resolved by electrophoresis on a
1.2% agarose gel and analyzed using a SYNGENEUGENIUS 3 gel
documentation system. The results were reported as presence or
absence of the virus(es) based on the detectability of the expected
PCR signal.
Analysis of CBSV and UCBSV Sequence
Diversity
In order to perform a virus diversity study, leaf samples were
collected from CBSD symptomatic wild-type TME 204 and local
cultivars within the CFT site at Namulonge and from within
the CFT and nearby field plots at Mtwapa. Leaves were pressed
and dried on newsprint as described above, and shipped to
DDPSC, St. Louis, MO, USA. Between 0.02 g and 0.05 g dried
leaf sample was removed from the pressed newsprint, placed
into a 2 ml screwcap tube and ground with a sterile ceramic
bead to a fine powder using a FastPrep-24 (MP Biomedical,
Solon, OH) set at 4.0m/s twice for 30 s, followed by addition
of 700µL of cetyltrimethylammonium bromide (CTAB) RNA
extraction buffer (Doyle and Doyle, 1990). Genomic DNA was
removed using the TURBO DNA-free
TM
Kit (Ambion, Houston,
Texas) and the resulting RNA run on a denaturing agarose
gel to check for quality. RNA was used for cDNA synthesis
and amplification of 3′-viral genomic regions of about 1607
bp (CBSV) and 1670 bp (UCBSV) essentially as described by
(Ogwok et al., 2015) using degenerate primer combinations
CBSVF2 (5′-GGRCCATACATYAARTGGTT-3′) (Mohammed
et al., 2012) and CBSVDR (5′- GGATATGGAGAAAGRKCTCC-
3′) (Mbanzibwa et al., 2011). PCR products were cloned as
described earlier (Ogwok et al., 2015) and sequenced using the
Sanger sequencing method. Raw sequence reads were processed
using Vector NTI Advance v11.5.3 (Invitrogen, Carlsbad CA,
USA). Cleaned sequences were subjected to homology search
using BLASTN (Zhang et al., 2000) and BLASTP (Altschul
et al., 1997) available at the National Center for Biotechnology
Information (NCBI) for virus species identification. Phylogenetic
analyses frommultiple sequence alignments were produced using
MUSCLE (Edgar, 2004) with default settings and phylogenetic
trees were viewed and edited using TreeGraph2 (Stover and
Muller, 2010).
Statistical Analysis
For CFT established with 30 entries/lines at Namulonge, Uganda,
eight replicated blocks were employed in a randomized complete
block design. Each entry was represented in plots consisting
of two parallel rows, each row with 5 plants, for a total of
10 plants. Data for early season assessment to estimate foliar
CBSD incidence and severity scores were collected from all eight
replicated blocks. The 6.5MAP assessment for storage root CBSD
incidence and severity was based on data collected from three
replicated blocks, each plot having ten plants per line. The 12
MAP data for both foliar and root CBSD incidence and severity
of the 30 entries were collected from the remaining five replicated
block, each plot consisting of ten plants per entry. Within each
plot at harvest (6.5 and 12 MAP) every plant was harvested
separately with all roots being segmented and scored for CBSD
symptoms on a plant by plant basis. For the CFT conducted
at Mtwapa, Kenya with 21 entries, data of foliar and storage
root CBSD incidence and symptom severity scores were collected
from four replicated blocks with each entry represented in plots
by paired rows of five plants each. For the stake-derived CFT
planting of 15 entries at Namulonge, Uganda, data for foliar
and root CBSD incidence and severity were collected from four
replicated blocks, each plot consisting of 25 plants (5 rows, 5
plants per row) per entry. Data for CBSD incidences and severity
scores were subjected to Analysis of Variance (ANOVA) using
ARM (Gylling Data Management, Inc., Brookings, SD, USA,
formerly Agriculture Research Manager Software). Wherever the
ANOVA process detected significant treatment (i.e., entry) effects
(Calculated F-test where p≤ 0.05), separation of means was done
using Duncan’s new multiple range test (alpha ≤ 0.05).
RESULTS
Selection and Establishment of Transgenic
p5001 Lines in CFTs
Production of TME 204 plants transgenic for the p5001 RNAi
construct, and confirmation of integrated T-DNA copy number
was reported by Chauhan et al. (2015). Lines with 1–2 copies
of p5001 T-DNA were characterized to determine levels of
CP-derived siRNA expression by Northern blot (Beyene et al.,
2016a). Transgenic lines expressing low, medium and high levels
of siRNAs derived from p5001 were evaluated by challenge with
CBSV and UCBSV using a bud grafting procedure for virus
inoculation under greenhouse conditions (Wagaba et al., 2013).
The level of resistance to these viruses was found to be positively
correlated with the levels of CP-derived siRNAs (Beyene et al.,
2016a).
To evaluate efficacy of the p5001 construct under whitefly
transmitted CBSD under field conditions, 25 independent
transgenic lines were planted at Namulonge, Uganda. Within
the 25 selected transgenic lines, seven lines expressed low,
and the remaining lines expressed medium to high levels, of
transgene-derived siRNAs (Table 1, Supplementary Figure S1).
In vitro plantlets from the 25 transgenic lines, including three
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TABLE 1 | siRNA expression levels of transgenic p5001 TME 204 lines tested in confined field trials at Namulonge, Uganda, Mtwapa, coastal Kenya, and
in a stake-derived trial at Namulonge, Uganda.
Line/Entry Relative expression level
(% of control)a
siRNA expressionb Tested in Namulonge CFT Tested in Mtwapa CFT Tested in Stake-derived
durability Trial
5001-01 66.9 +++ Yes Yes Yes
5001-08 97.3 +++ Yes Yes Yes
5001-09 100.3 +++ Yes No No
5001-10 99.6 +++ Yes Yes Yes
5001-16 7.8 + Yes Yes No
5001-18 82.0 +++ Yes Yes Yes
5001-20 28.1 + Yes Yes No
5001-22 56.0 ++ Yes No No
5001-25 73.7 +++ Yes No No
5001-26 72.7 +++ Yes Yes Yes
5001-27 34.1 + Yes No No
5001-30 79.7 +++ Yes Yes Yes
5001-34 99.3 +++ Yes Yes Yes
5001-35 102.5 +++ Yes Yes Yes
5001-40 19.9 + Yes Yes No
5001-42 98.6 +++ Yes Yes No
5001-45 23.0 + Yes No No
5001-46 78.7 +++ Yes Yes Yes
5001-47 79.0 +++ Yes Yes Yes
5001-48 10.6 + Yes No No
5001-50 75.3 +++ Yes Yes Yes
5001-53 40.1 ++ Yes Yes No
5001-69 76.7 +++ Yes Yes No
5001-76 45.5 ++ Yes Yes No
5001-77 75.2 +++ Yes Yes No
718-01 100.0 +++ No No No
asiRNA expression expressed relative to signal intensity of control line 718-01 (Ogwok et al., 2012) set at 100%.
bRanking of transgenic lines based on siRNA expression levels (+ = low, 0–33.3% of control line 718-01 ++ = medium 33.4–66.6% of control line 718-01 and +++ high, 66.7–100%
or more of control line 718-01).
non-transgenic entries of TME 204, were used to establish a CFT
consisting of eight replications. Each plot contained 10 plants
per entry, resulting in 80 plants per line for a total of 2000
transgenic plants. Locally sourced CBSD-free stake cuttings of
CBSD tolerant cultivars NASE 3 and NASE 14 were included in
the field trial for comparison.
Foliar and Storage Root CBSD Incidence
and Severity
All experimental plants in the field were assessed on a monthly
basis for presence and severity of CBSD and CMD symptoms on
leaves and stems. CMD incidences on these lines was reported
recently (Beyene et al., 2016b). In an initial CFT established at
Namulonge, foliar symptoms of CBSD on wild-type TME 204
plants became visible at 2 MAP. All three wild-type TME 204
entries displayed foliar CBSD incidences that reached 96–100%
by 12 MAP (Figure 1A, Supplementary Figure S3). Average
CBSD symptom severity at 6 MAP ranged from 2.6 to 2.9 (scale
of 1–5), increasing to 3.2–3.4 by 12 MAP (Table 1). CBSD
foliar incidences were seen to be present on the local control
cultivars NASE 3 and NASE 14 at 48 and 90%, respectively, by
6 MAP (Supplementary Figure S3), increasing to 71 and 100%,
respectively, by 12 MAP (Figure 1A) and showing average CBSD
severity scores of 4.4 and 4.3 at 12 MAP (Table 2). Performance
of the transgenic lines contrasted significantly with the wild-
type TME 204 and local controls. Sixteen of the 25 TME 204
transgenic lines remained free of CBSD foliar symptoms across
the full 12-month growing cycle (Figure 1A, Supplementary
Figure S3). The nine transgenic lines that developed foliar
CBSD symptoms did so at incidences that ranged between 2.5%
(5001-22) and 96% (5001-40). No new transgenic lines developed
foliar CBSD symptoms between 6 and 12 MAP. However, as
seen for the non-transgenic TME 204 controls (Figure 1A;
Supplementary Figure S3), the severity of foliar symptoms in
infected transgenic lines continued to increase until harvest at 12
MAP (Table 2).
At 6.5 and 12 MAP, storage roots were harvested and assessed
for CBSD-induced necrosis. At 6.5 MAP, three replicates were
harvested and CBSD root damage assessed by slicing each storage
root transversely five times along its length and scoring each
slice for presence and severity of necrosis on a scale of 1–5
(Ogwok et al., 2012). Storage roots from all plants in all three
entries of wild-type TME 204 displayed CBSD at 6.5 MAP, while
local control cultivars NASE 3 and NASE 14 had incidences of
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FIGURE 1 | Incidence of CBSD symptoms on shoots and storage roots of transgenic TME 204 plant lines, non-transgenic TME 204 controls and local
cultivars NASE 3 (TMS 30572) and NASE 14 at 12 months after planting within a confined field trial at Namulonge, Uganda. TME 204 lines were
established from tissue culture-derived plants transgenic for inverted repeat construct p5001 that consists of coat protein (CP) genes of Ugandan Cassava brown
streak virus (UCBSV) and Cassava brown streak virus (CBSV) fused in tandem. (A) Shoot CBSD incidence and (B) storage root CBSD incidence. TME 204-WT1 and
-WT2 represent entries of wild-type TME 204 derived from in vitro micro-propagated plants. Entries TME 204-WT3, NASE 3, and NASE 14 wild-type plants were
derived from disease-free stake cuttings obtained from farmers’ fields. Storage roots were sliced transversely five times along their length and visually assessed for
presence of CBSD symptoms. Data were collected from replicated plots of 10 plants each and are presented as the average percentage of plants showing CBSD
symptoms across the five plots. Approximately five storage roots were assessed per plant. Presence of CBSD within one or more storage roots resulted in a positive
score for that plant. Means followed by the same letter are not significantly different (P ≤ 0.05, Duncan’s multiple range test).
CBSD at 75 and 100%, respectively (Supplementary Figure S3).
In contrast, 16 of the 25 transgenic lines were found to have
significantly lower averages of CBSD incidence with less than
20% of their plants carrying one or more storage roots showing
CBSD symptoms (Supplementary Figure S3). At 12 MAP, the
remaining five replicate plots were harvested and storage roots
sliced and evaluated for presence and severity of CBSD. Eleven
transgenic lines continued to have less than 20% of their plants
(498 total plants examined) showing CBSD in one or more of
their storage roots (Figure 1B). These transgenic lines showed
average severity scores of between 2.0 and 2.7 (Table 2). In
contrast, CBSD incidence in the wild-type TME 204 and local
controls ranged between 80-100%, with average severity scores
of 4.0-4.5 (Table 2, Figure 1B).
A total of 7242 storage roots were evaluated at 12 MAP (6346
roots from the transgenic lines and 896 roots from wild-type
controls). The number of roots per plant line showing CBSD
symptoms is presented in Figure 3. In 16 of the 25 transgenic
lines, over 90% of the storage roots remained free from CBSD
symptoms. For 12 of these lines, less than 5% of the storage
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roots displayed CBSD. In contrast, the three entries of wild-type
TME 204 had 95-100% of their storage roots symptomatic for
CBSD, with only 14 roots free of CBSD out of a total of 761 roots
assessed (Figure 2, Table 2). The number of roots showing CBSD
symptoms in the local cultivars NASE 3 and NASE 14 was also
high at 87–89% (Figure 3).
Storage roots carrying very mild CBSD symptoms still have
value and can be consumed. In order to determine the impact of
CBSD on marketable/usable root yields, CBSD symptom severity
data was re-analyzed, defining usable storage roots as those with
scores of 1–2 on the severity scale of 1–5, similar to breeders’
practices employed for line selection (Kawuki et al., 2016). Based
on this assessment, the wild-type TME 204 and local controls had
between 0% and 25% usable storage roots at 12 MAP while 11
of the 25 transgenic TME 204 lines had 98–100% of their roots
defined as usable (Table 2).
Populations of adult whitefly counted on the five uppermost
leaves steadily increased from planting to a maximum
average of 310 per plant at four MAP and declining to less
than 10 whiteflies per plant at 11 MAP (Supplementary
Figure S2). There was no vector preference observed within
transgenic lines, or between the transgenic and non-transgenic
TME 204 control plants and local varieties (Supplementary
Figure S2).
Correlation of Resistance to CBSD with
Expression of Transgene-Derived siRNA
Levels of transgene-derived (CBSV-CP and UCBSV-CP) siRNAs
accumulating within tissues of the 25 p5001 lines cultivated in
the CFT at Namulonge were determined before plants were
established in the field (Supplementary Figure S1). Incidence of
CBSD symptoms directly correlated with levels of accumulated
CP-derived siRNAs in the transgenic lines. Plant lines that
accumulated medium to high levels of transgene CP-derived
siRNAs displayed very high resistance against CBSD. These
lines displayed no foliar symptoms and had very low incidence
of symptomatic storage roots (Figures 1–3). Transgenic TME
204 lines classified as low siRNA expressers (5001-16, 5001-
20, 5001-27, 5001-40, 5001-45, and 5001-48) showed lower
resistance to CBSD under field conditions at Namulonge
(Figures 1–3). This was reflected by CBSD incidence in shoots
and storage roots and in the proportion of marketable storage
roots. A strong Pearson correlation (r = −0.87) was observed
between levels of transgene-derived siRNA expression level
and foliar CBSD incidence (Figure 4A), and likewise between
transgene derived siRNA expression and percentage of CBSD
symptomatic storage roots (r = −0.84, Figure 4B). The most
resistant lines showed the highest levels of CP-derived siRNA
expression.
FIGURE 2 | Impact of CBSD on storage roots of cassava harvested from transgenic and non-transgenic plants 12 months after planting in a confined
field trial at Namulonge, Uganda. Twenty-five RNAi plant lines of cultivar TME 204 transgenic for the inverted repeat construct p5001 were assessed in addition to
three wild-type entries of TME 204 (WT1, WT2, and WT3) plus non-transgenic local cultivars NASE 3 and NASE 14. At harvest, all storage roots were uprooted and
sliced transversely five times along their length. A root was assessed positive for presence of CBSD if symptoms were visible on one or more of the slices. Total
number of storage roots examined for each transgenic line is shown within the bar. Storage roots free of CBSD symptoms are indicated in green with those positive
for presence of CBSD represented in red.
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FIGURE 3 | CBSD symptoms within storage roots of cassava harvested from transgenic and non-transgenic plants 12 months after planting in a
confined field trial at Namulonge, Uganda. (A) Representative storage root slices from high CP-derived siRNA-accumulating transgenic lines 5001-10, 47, 18,
and 26 showing no CBSD symptoms (B) storage root slices from representative low CP-derived siRNA accumulating lines 5001-40 and 5001-27 showing CBSD
symptoms, (C) root slices of CBSD symptomatic wild-type TME 204 (left) and non-transgenic local cultivar NASE 3 (right) showing severe symptoms of CBSD.
p5001-Imparted Resistance across the
Vegetative Cropping Cycle
Durability of resistance to CBSD imparted by p5001 was
assessed across the vegetative cropping cycle by establishing
a CFT at Namulonge with stake cuttings obtained from the
initial CFT described above. Stem cuttings were generated from
plants harvested at 6.5 MAP. Eleven transgenic lines showing
no visual foliar CBSD symptoms and minimum root CBSD
incidences (Table 1, Supplementary Figure S3) were selected,
planted and grown for a period of 8 months. In addition,
controls were established from stem cuttings obtained from
CBSD- and CMD-free plants of TME 204 obtained from a
farmer’s field.
Whereas very high whitefly populations were observed within
the initial CFT established from tissue culture-derived plants,
insect counts remained relatively low in the durability trial with
peak average populations of 19 per plant by two MAP (data not
shown). However, more than 61% of TME 204 plants established
from disease-free stem cuttings developed CBSD on their foliar
tissues by 8 MAP (shown as WT2 in Supplementary Table S1),
indicating that new infections were being vectored into this CFT.
All p5001 transgenic TME 204 plants remained free of visible
CBSD foliar symptoms over the eight-month growing period
(Supplementary Table S1).
At 8 MAP, storage roots were harvested and assessed by
transverse slicing as described above to determine levels of
CBSD-induced damage. None of the 11 transgenic p5001
lines had CBSD symptomatic roots (Figures 5A,B), and all
harvested storage roots were therefore classified as usable. Both
TME 204 non-transgenic entries developed storage root CBSD
incidences of 99% (Figure 5) and average severity scores of
3.9–4.1 (Supplementary Table S1). The local controls NASE
3 and NASE 14 were also severely impacted by CBSD,
displaying incidences at 68 and 59%, respectively (Figure 5)
with average severity scores of 3.6 and 3.4 (Supplementary
Table S1).
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FIGURE 4 | Correlation between levels of transgene-derived siRNA expression and visual incidence of CBSD symptoms in TME 204 plant lines 12
months after planting in a confined field trial at Namulonge, Uganda. Twenty-five plant lines for the inverted repeat construct p5001 were assessed for levels
of transgene-derived siRNA accumulation by Northern blot analysis from in vitro-grown plants before establishment in the field. Signal intensities of the small RNA
blots were analyzed using ImageJ software and values were normalized against the known high siRNA-expressing cassava plant line 718-01 (Ogwok et al., 2012).
Northern blot numerical expression values of each line were plotted against CBSD incidence. (A) Relationship between UCBSV-derived siRNA expression with foliar
CBSD incidence at 12 MAP, (B) relationship between UCBSV-derived siRNA expression with percentage of CBSD symptomatic storage root at 12 MAP.
RT-PCR Detection of CBSD Causal Viruses
in the CFTs
Presence of CBSV and UCBSV within the CFTs was determined
using species-specific primers (Mbanzibwa et al., 2011). Pools
of five leaf samples obtained from asymptomatic plants were
analyzed at 7MAP by RT-PCR. All asymptomatic transgenic lines
were seen to be free of detectable viruses in both the initial trial
and the stake- derived trial (Table 3). Wild-type TME 204 control
samples, in contrast, were found to carry both CBSV and UCBSV,
present either as single or dual infections in up to 87.5% of the
samples analyzed (Table 3).
Performance of Transgenic p5001 Lines at
Mtwapa, Kenya
Performance of TME 204 plants expressing the p5001 RNAi
construct was assessed at Mtwapa, coastal Kenya, to determine
their resistance to CBSD under different agro-ecological
conditions from that present at Namulonge. The Mtwapa CFT
was established with a subset of 19 of the 25 lines tested at
Namulonge, plus two entries of non-transgenic TME 204. The 19
transgenic lines were chosen to include 14 that expressedmedium
to high, and five that expressed low levels of transgenic CP-
derived siRNAs (Table 1, Supplementary Figure S1). By 12 MAP,
10 of the 19 transgenic lines had developed visible foliar CBSD
symptoms with incidences ranging between 3–8% and average
severity scores of 2.0–3.0 (Table 4). Foliar CBSD symptoms of
the two wild-type entries were seen at 100% with average severity
scores at or close to 3.0 (Table 4).
Storage roots from a total of 40 plants per line (4 replicates
of 10 plants each) were harvested at 12 MAP and evaluated
for presence and severity of CBSD symptoms. The frequency of
plants showing CBSD symptoms in their storage roots ranged
between 10.0 and 47.5% in the transgenic p5001 lines with seven
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FIGURE 5 | Incidence of CBSD symptoms in storage roots of transgenic TME 204 p5001 lines, non-transgenic wild-type TME 204 and local controls in
a stake-derived field trial at Namulonge, Uganda. Stem cuttings obtained from the first trial at Namulonge (Figures 1–3) were used to establish a second trial to
determine durability of p5001-imparted RNAi resistance to CBSD. Plants of TME 204-WT2 were established from disease-free cuttings obtained from a farmer’s field.
(A) Incidence of CBSD symptoms in storage roots at 8 months after planting. Data per line represents average number of plants showing CBSD symptoms in their
storage roots expressed as percentage. Means followed by same letter do not significantly differ (P ≤ 0.05, Duncan’s multiple range test). (B) CBSD symptoms within
storage roots of representative transgenic lines 5001-34, 5001-35, and 5001-50; symptomatic wild-type TME 204; and non-transgenic local control NASE 3.
of these lines showing incidences of 10–20% (Figure 6). The two
wild-type entries of TME 204 had CBSD incidences of 97.5–100%
(Figure 6).
The total number of roots per line showing CBSD symptom
was also determined across the total of 5155 storage roots
evaluated. Storage roots showing any CBSD symptoms (score
greater than 1 in 1–5 scale) ranged between 2.5–13.5% for the
19 transgenic lines, of which 15 had less than 10% of their storage
roots symptomatic for CBSD (Figures 7A,B). This compared to
87–96% symptomatic storage roots for the two entries of wild-
type TME 204. Evaluation of the marketable/usable roots was
assessed by counting all roots with CBSD severity scores of 2
or less. Non-transgenic wild-type TME 204 had only 10–24% of
their storage roots assessed to be usable at 12 MAP. In contrast,
15 of the 19 transgenic lines had usable yield losses of 2% or less
when assessed in this manner (Table 4).
Sequence Diversity of CBSV and UCBSV at
the CFT Sites
The genetic diversity of CBSV and UCBSV viruses infecting
cassava plants within and surrounding the CFT locations at
Namulonge and Mtwapa was investigated. Over 100 samples
were obtained as dried pressed leaves, processed, cloned and
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TABLE 3 | Reverse transcriptase-polymerase chain reaction (RT-PCR) diagnostics for simultaneous detection of Cassava brown streak virus (CBSV) and
Ugandan Cassava brown streak virus (UCBSV) at 7 months after planting in confined trials conducted at Namulonge, Uganda.
Line/entrya Trial established from tissue culture-derived plantlets Durability trial established from stake-derived cuttings
Number of samples
analyzedb
Positive
samples (%)
Only CBSV
(%)
Only UCBSV
(%)
CBSV &
UCBSV (%)
Positive
samples (%)
Only CBSV (%) Only UCBSV
(%)
CBSV &
UCBSV (%)
5001-01 8 0 0 0 0 0 0 0 0
5001-08 8 0 0 0 0 0 0 0 0
5001-09 8 0 0 0 0 n/a n/a n/a n/a
5001-10 8 0 0 0 0 0 0 0 0
5001-18 8 0 0 0 0 n/a n/a n/a n/a
5001-25 8 0 0 0 0 n/a n/a n/a n/a
5001-26 8 0 0 0 0 0 0 0 0
5001-30 8 0 0 0 0 0 0 0 0
5001-34 8 0 0 0 0 0 0 0 0
5001-35 8 0 0 0 0 0 0 0 0
5001-42 8 0 0 0 0 n/a n/a n/a n/a
5001-46 8 0 0 0 0 0 0 0 0
5001-47 8 0 0 0 0 0 0 0 0
5001-50 8 0 0 0 0 0 0 0 0
5001-69 8 0 0 0 0 0 0 0 0
5001-77 8 0 0 0 0 n/a n/a n/a n/a
TME 204-WT1 8 87.5 37.5 12.5 37.5 87.5 12.5 12.5 50
TME 204-WT2 8 87.5 12.5 12.5 62.5 87.5 25 37.5 37.5
a-WT1 and -WT2 represent entries of wild-type TME 204 derived from tissue culture micro-propagated plants. TME 204-WT2 in durability trial is established from locally sourced stake
cuttings. N/A, denotes samples not assayed.
bLeaves from five randomly selected plants were sampled per plot and pooled for RNA extraction and virus diagnostics.
sequenced. The sequenced fragments identified 34 and 38 non-
redundant isolates from Namulonge and Mtwapa, respectively.
A BLAST search (NCBI) showed that at Namulonge, 31 out of
the 34 isolates were CBSV, with the remaining three identified
as UCBSV. Unlike Namulonge, isolates from Mtwapa were more
evenly balanced between CBSV and UCBSV, with 20 samples
corresponding to CBSV and 17 to UCBSV. Sequence alignments
and analysis showed that the CBSV sequences were 86–99%
identical at nucleotide level. A phylogenetic analysis sub-divided
the CBSV into four clusters with sequences in each cluster having
distinct geographical origins (Figure 8). Cluster I contained 30
sequences with nucleotide identity ranging between 97 and
99%. This cluster was the largest of the four, and contained
isolates from the Ugandan site alone. These isolates were 90–91%
identical to the CBSV sequence (CBSV[TZ:Nal3-1:07, GenBank
HG965221) used to generate the inverted repeat expression
cassettes present in p5001. Cluster III and IV consisted of CBSV
isolates from Mtwapa, Kenya. Sequences from cluster III were
99% identical to each other, and 92% identical to the p5001
reference sequence HG965221 at the nucleotide level. Sequences
in cluster IV were 96–99 and 90–93% similar to each other and
the reference sequence, respectively. Cluster II contained only
two isolates collected from Namulonge and Mtwapa and were
93% identical to the CBSV HG965221 reference sequence. All 20
UCBSV isolates (three from Namulonge and 17 from Mtwapa)
clustered together with sequence identity that ranged between
92–98%, and had 92–98% similar identity to the reference
sequence (UCBSV[UG:T04-42:04, GenBank HG965222) used
to generate the inverted repeat in the p5001 inverted repeat
construct (Figure 8).
DISCUSSION
Cassava cultivar TME 204 was genetically modified to express
siRNAs derived from the inverted repeat construct p5001
consisting of fused CP sequences from CBSV and UCBSV
(Chauhan et al., 2015; Beyene et al., 2016a). TME 204 is
a Ugandan farmer-preferred cultivar possessing good root
characteristics, early maturation time and robust resistance
to CMD. It is, however, highly susceptible to CBSD. These
qualities make TME 204 an ideal target for improvement within
the VIRCA project, which aims to bring CMD- and CBSD-
resistant planting material to smallholder farmers in East Africa
(Taylor et al., 2012). We previously reported field resistance
to CBSD generated from an inverted repeat construct carrying
the CP of UCBSV (p718) (Ogwok et al., 2012; Odipio et al.,
2014). While high levels of resistance to the homologous virus
species was achieved in p718 transgenic plants, resistance to
CBSV was restricted to two lines that accumulated CP-derived
siRNAs at very high levels (Ogwok et al., 2012). Susceptibility
of these lines to CBSV was confirmed by Beyene et al. (2016a),
when p718 transgenic plants were bud graft inoculated with
CBSV. Recognizing the need for integration of more robust
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FIGURE 6 | Incidence of CBSD symptoms in storage roots of transgenic TME 204 plant lines and non-transgenic TME 204 controls at 12 months after
planting within a confined field trial at Mtwapa, Kenya. The 19 transgenic TME 204 lines studied were generated using the p5001 construct. TME 204-WT1 and
-WT2 are two entries of wild-type TME 204 derived from in vitro micro-propagated plants. Data were collected from four replicated plots of 10 plants each. Storage
roots were sliced five times along their length and visually assessed for presence of CBSD symptoms. Data is presented as the average percentage of plants showing
CBSD symptoms across the four plots. Approximately five storage roots were assessed per plant. Presence of CBSD within one or more storage roots resulted in a
positive score of that plant. Means followed by the same letter are not significantly different (P ≤ 0.05, Duncan’s multiple range test).
resistance against both CBSD causal viruses, plants of TME
204 were generated with the p5001 construct (Chauhan et al.,
2015; Beyene et al., 2016a). Proof of efficacy under greenhouse
conditions against inoculation with CBSV and UCBSV led to
the establishment of a field trial program in East Africa where
the plants were exposed to the pathogens transmitted by whitefly
vector.
Field performance of p5001 transgenic plants against CBSD
exceeded expectations. Under field conditions at Namulonge,
Uganda, in which 95–100% of non-modified TME 204 plants
developed symptoms, 16 of the 25 lines developed no foliar
symptoms and showed significantly reduced (<20%) CBSD
symptom incidences in storage roots (Figures 1–3) over the 12-
month growing period. Similar results were obtained in Mtwapa
where 7 of the 19 lines tested displayed 10–20% CBSD incidences
in their storage roots. Efficacy of RNAi-imparted resistance was
most dramatically seen when comparing the impact of CBSD
on usable storage root yields, defined as roots carrying no more
than a disease severity score of 2 (scale 1–5). In this case more
than 95% of storage roots produced by the non-transgenic TME
204 were lost to disease (score of 3 or more). Under the same
conditions in both central Uganda and coastal Kenya, the best
performing transgenic lines lost no more than 2% of their roots
to damage from CBSD (Figures 2, 7, Tables 2, 4).
In all cases the best performing plant lines were those that
accumulated higher levels of transgene CP-derived siRNAs.
Greenhouse studies indicated a positive correlation between
levels of p5001 CP-derived siRNAs and resistance to challenge
with CBSV and UCBSV (Beyene et al., 2016a). The 25 p5001
transgenic lines selected for testing under CFT conditions
confirmed that this phenomenon translates to the field, and that
levels of siRNA determined from plantlets as early as 4 weeks
after regeneration in tissue culture can be used as a signature
for subsequent vector-transmitted field-level performance
against the virus pathogens (Figures 1–6). This has important
implications for streamlining product development, allowing
effective selection for CBSD-resistant plant lines as early as the
newly regenerated in vitro plantlet. Only high CP-derived siRNA
accumulating lines need then be taken through the pipeline to
field-testing stages. Likewise, mid-season assessments of storage
roots (6.5 MAP) tracked consistently well with end of season
p5001 TME 204 performance (strong age to age correlation)
indicating the possibility of early phenotype screening and
identification of adapted lines in high CBSD disease locations.
The overall incidence and severity of CBSD on transgenic
lines seen at Mtwapa was lower than that recorded at Namulonge
(Figures 1–7, Tables 2, 4). Impact of CBSD remained high, with
greater than 90% of non-transgenic storage roots impacted by
disease. Across the 10 transgenic lines, all but two recorded
presence of CBSD to be less than 10% of their roots (Figure 7).
The resistance conferred by p5001 and ranking of events
accumulating lower levels of CP-derived siRNAs at this location
may suggest differences in virulence of the CBSD causal
pathogens and/or a combination of the environment and CBSD
pressure. Year-to-year variation in CBSD incidence and severity
has been reported at the same location (Kawuki et al., 2016).
Indeed, data generated from the diversity study reported here
indicates presence of a cluster of CBSV isolates at Namulonge
(Cluster I) (Figure 8) that was not found at the Mtwapa location
(Figure 8).
Successful deployment of CBSD-resistant planting materials
depends not just on levels of resistance to the pathogen, but also
durability of the trait over cropping cycles, and the geographical
range in which effective resistance can be maintained. Highly
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FIGURE 7 | Impact of CBSD on storage roots of cassava harvested from transgenic and non-transgenic plants 12 months after planting in a confined
field trial at Mtwapa, Kenya. (A) Nineteen RNAi plant lines of cultivar TME 204 transgenic for the inverted repeat construct p5001 were assessed in addition to two
wild-type entries of TME 204 (-WT1, -WT2). At harvest, all storage roots were uprooted and sliced five times along their length. A root was assessed positive for
presence of CBSD if symptoms were visible on one or more of the slices. Total number of storage roots examined for each transgenic line is shown within the bar.
Storage roots free of CBSD symptoms are indicated in green with those positive for presence of CBSD represented in red. (B) Representative storage root slices from
plants of non-transgenic TME 204 (upper and lower left) and two RNAi transgenic plant lines (upper and lower right).
specific pathogen-derived resistance restricted to a narrow agro-
ecological area, as seen for Papaya ringspot virus in Hawaii
(Tennant et al., 1994), would prevent deployment of RNAi
technology in cassava due to the dynamic nature of the disease
complex and its insect vector across East and Central Africa (Legg
et al., 2014; Ndunguru et al., 2015; Patil et al., 2015). Effective
siRNA-derived resistance to CBSD across the vegetative cropping
cycle reported here (Figure 5) demonstrates durability of the trait
under practices similar to those used by farmers. Indeed, data
presented showed that resistance in the stake-derived generation
was equal or superior to that of tissue culture-derived plants at
the same location (Figures 1–3). Proof of resistance to CBSD in
diverse locations in central Uganda and coastal Kenya indicates
that plants expressing siRNAs from the p5001 construct would
have value across a significant part of East Africa. Efficacy of the
p5001 transgenic lines in these diverse locations is possibly due
to abundance of the transgene-derived siRNA produced in the
resistant lines and the high CP sequence similarity (92.8–99.6%
for UCBSV and 91.3–94.1% for CBSV) between the CP sequences
of the transgene and the isolates present across these two CFT
locations (Supplementary Tables S2, S3). It remains unclear if
all regions within the CP sequences provide siRNAs that impart
resistance to CBSD, or if this is restricted to specific regions.
Successful demonstration of RNAi for control of CBSD
reported here would normally lead to the best performing
lines being advanced for subsequent yield and regulatory CFTs.
As reported previously (Beyene et al., 2016b), however, all 25
transgenic TME 204 plant lines were found to be susceptible
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FIGURE 8 | Phylogenetic analysis of CBSV and UCBSV based on alignment of nucleotide sequences derived from the 3′-end of the virus genome,
including the full-length CP regions. Virus samples were collected from within the field trial site and nearby plots in Mtwapa, Kenya and within the field trials at
Namulonge, Uganda in 2013 and 2014. The numbers at nodes are percentage bootstrap confidence scores (1000 replicates). The tree was arbitrarily rooted on the
cognate sequence of Cucumber vein yellowing virus (AY578085). The 3′ genomic region of the two reference isolates (rectangular boxes) from which coat protein
nucleotide sequences were obtained for making the p5001 inverted repeats CBSV isolate CBSV-[TZ:Nal:07] GenBank HG965221: 7331-8937 and UCBSV isolate
UCBSV-[UG-T04-42:04] GenBank HG965222: 7315-8984 were included for comparison. Nucleotide sequences of clones identified in this study are deposited in
public database with accession numbers (GenBank LT560259-LT560330).
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to CMD under field conditions at Namulonge and Mtwapa.
Extensive experimentation has since confirmed that loss of
resistance to CMD was not as a result of p5001-derived siRNA
expression, but occurred during the earliest steps in the induction
of the embryogenic tissues employed for production of these
and other transgenic cassava plants (Chauhan et al., 2015;
Beyene et al., 2016b). Two parallel approaches are being pursued
to circumvent this unforeseen phenomenon and capitalize
on the proven efficacy of p5001 for imparting resistance to
CBSD. Firstly, in order to generate stacked resistance to both
CMD and CBSD in the resulting progeny, p5001 TME 204
transgenic plants are being crossed with non-transgenic CMD2-,
CMD1- and CMD3-type cassava cultivars. Secondly, p5001 is
being integrated into CMD1-and CMD3-type cultivars via new
Agrobacterium-mediated transformations based on knowledge
that these cultivars do not lose resistance to CMD when passed
through somatic embryogenesis (Beyene et al., 2016b). Efficacy of
RNAi to control CBSD has been demonstrated through a series
of greenhouse (Beyene et al., 2016a) and field studies, the latter
in diverse geographical regions of high disease pressure. Similar
resistance to virus disease and subsequent regulatory approval
for planting by farmers has been achieved in papaya (Fuchs and
Gonsalves, 2007), squash (Gottula and Fuchs, 2009), plum (Hily
et al., 2004; Scorza et al., 2013), and common bean (Aragao
et al., 2013). Targeting introgression of this technology into
cassava germplasm with inherent resistance to CMD therefore
holds potential for delivering CBSD-resistant planting materials
to farmers and breeders in East and Central Africa, and as a
preemptive measure against likely progression of this destructive
disease into West Africa.
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